학술논문
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
Document Type
Article
Author
Source
European Journal of Preventive Cardiology; Aug2021, Vol. 28 Issue 8, p816-822, 8p
Subject
Language
ISSN
20474873